Candel Therapeutics develops viral immunotherapies that are injected into tumors to fight cancer. It last closed at $5.04 on Nov 20, down 1.75% on the day. The next earnings report for CADL is expected around Thu, Feb 18, 2027, after the close. For the quarter ended Sep 2026, CADL reported EPS of -$0.28. Over its last 8 reports the stock moved an average of 10.2% the session after earnings. Over the last 12 months CADL insiders bought $3.0M of stock on the open market and sold $3.6M, according to SEC Form 4 filings.
AI Auto Pilots
Is CADL in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold CADL.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on CADLStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
CADL · as of the Nov 20 close · updated each morning
Downtrend, oversold
The stock is 53% below its 20 day and 81% below its 50 day average. It is 67% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 26), oversold. The nearest support is the Pivot S1 at $4.86, and the nearest resistance the Pivot at $5.08.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 14.4%/day
Key levels
$14.0052 week high+177.8%
$10.10100 day average+100.4%
$9.1050 day average+80.6%
$8.93Swing high (Oct 29)+77.2%
$8.40200 day average+66.7%
$7.6920 day average+52.6%
$5.27Pivot R1+4.6%
$5.08Pivot+0.8%
$5.04Last close
$4.86Pivot S1−3.6%
$4.3552 week low−13.7%
Indicators
RSI (14)
26.00
Oversold below 30
Oversold
MACD
-1.06
Below its signal line
Bearish
Stochastic
2.2
Near the bottom of its range
Oversold
ADX (14)
37.0
Trending down
Williams %R
-97.2
Oversold below −80, overbought above −20
Oversold
CCI (20)
-134.3
Oversold below −100, overbought above 100
Oversold
Rate of change
−42.4%
Change over 10 sessions
Bearish
ATR (14)
$0.72
Typical daily range, 14.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Pullback inside a longer uptrend, oversold
Short trendBearish
Long trendBullish
MomentumWeak
StretchOversold
VolatilityNormal, 31.1%/day
Key levels
$14.0052 week high+177.8%
$10.10100 day average+100.4%
$9.1050 day average+80.6%
$8.93Swing high (Oct 29)+77.2%
$8.40200 day average+66.7%
$7.6920 day average+52.6%
$5.27Pivot R1+4.6%
$5.08Pivot+0.8%
$5.04Last close
$4.86Pivot S1−3.6%
$4.3552 week low−13.7%
Indicators
RSI (14)
31.30
Weak, oversold below 30
Neutral
MACD
-0.38
Below its signal line
Bearish
Stochastic
9.9
Near the bottom of its range
Oversold
ADX (14)
31.8
Trending down
Williams %R
-98.5
Oversold below −80, overbought above −20
Oversold
CCI (20)
-216.3
Oversold below −100, overbought above 100
Oversold
Rate of change
−52.2%
Change over 10 sessions
Bearish
ATR (14)
$1.57
Typical daily range, 31.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for CADL
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how CADL did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow CADL usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for CADLHow many large options trades hit CADL, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in CADL in the last 90 days.
From SEC Form 4 filings by CADL's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CADL is in one of them and how their past CADL trades turned out.
Candel Therapeutics is a clinical stage biopharmaceutical company based in Needham, Massachusetts. It develops viral immunotherapies for cancer, which are engineered viruses injected directly into tumors to stimulate the body's immune system against cancer. Its lead candidate, aglatimagene besadenovec, is being studied mainly for localized prostate cancer and for lung cancer. Its treatments are aimed at patients with a range of solid tumors.